These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 787583

  • 1. [Immunologic background of overlap syndrome--studies on humoral immunity].
    Tojo T.
    Nihon Rinsho; 1976 Jun; 34(6):1178-82. PubMed ID: 787583
    [No Abstract] [Full Text] [Related]

  • 2. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP.
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract] [Full Text] [Related]

  • 3. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T, Kahn MF, Peltier AP, de SEZE S.
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract] [Full Text] [Related]

  • 4. [Immune diagnosis of collagen diseases].
    Sönnichsen N.
    Z Arztl Fortbild (Jena); 1981 Jun 01; 75(11-12):519-21. PubMed ID: 6975540
    [No Abstract] [Full Text] [Related]

  • 5. Clinical significance of native DNA antibodies in systemic lupus erythematosus and other connective tissue diseases.
    Webb J, Whaley K, Lee P.
    Scott Med J; 1974 Jul 01; 19(4):171-5. PubMed ID: 4209789
    [No Abstract] [Full Text] [Related]

  • 6. [Anti-nuclear antibodies in collagen diseases].
    Gintz B, Phelip X, Micouin C, Cabanel G.
    Sem Hop; 1975 Feb 20; 51(9):573-80. PubMed ID: 169588
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
    Parker MD, Turner RA.
    Arthritis Rheum; 1976 Feb 20; 19(5):857-61. PubMed ID: 786297
    [Abstract] [Full Text] [Related]

  • 8. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D, Rovenský J, Cebecauer L, Hajzok O.
    Fysiatr Revmatol Vestn; 1973 Jun 20; 51(3):152-7. PubMed ID: 4592583
    [No Abstract] [Full Text] [Related]

  • 9. Anti-dsDNA antibodies in sera of patients without systemic lupus erythematosus.
    Wollina U.
    Allerg Immunol (Leipz); 1984 Jun 20; 30(4):222-4. PubMed ID: 6240935
    [Abstract] [Full Text] [Related]

  • 10. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S, Błaszczyk M, Górkiewicz A, Jarzabek-Chorzelska M, Rzesa G, Chorzelski T.
    Arch Immunol Ther Exp (Warsz); 1978 Jun 20; 26(1-6):765-8. PubMed ID: 312085
    [Abstract] [Full Text] [Related]

  • 11. [Autoantibodies in collagen diseases].
    Meyer O.
    Ann Med Interne (Paris); 1986 Jun 20; 137(8):666-78. PubMed ID: 2436515
    [No Abstract] [Full Text] [Related]

  • 12. [T- and B-lymphocytes in the so-called collagenoses].
    Standhofer M, Fritz J, Grond K, Klein G.
    Z Rheumatol; 1975 Jun 20; 34(11-12):418-24. PubMed ID: 1082214
    [Abstract] [Full Text] [Related]

  • 13. [Autoallergic diseases. II].
    Feo F.
    Minerva Med; 1978 Oct 27; 69(51):3546-9. PubMed ID: 83553
    [No Abstract] [Full Text] [Related]

  • 14. [DNA-antibodies in patients with lupus erythematosus, scleroderma and blister-forming skin diseases].
    Kerl H, Sandhofer M, Klein G, Altmann H.
    Hautarzt; 1975 Jan 27; 26(1):30-4. PubMed ID: 1090563
    [No Abstract] [Full Text] [Related]

  • 15. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O, Haim T, Ryckewaert A.
    Rev Rhum Mal Osteoartic; 1983 Apr 27; 50(4):261-6. PubMed ID: 6348931
    [Abstract] [Full Text] [Related]

  • 16. [Analysis of antinuclear antibodies (including LE test)].
    Tsunematsu T, Nakagawa J, Kusudo K.
    Nihon Rinsho; 1976 Apr 27; 34 suppl():2619-31. PubMed ID: 62859
    [No Abstract] [Full Text] [Related]

  • 17. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y, Lotan C.
    Isr J Med Sci; 1982 Feb 27; 18(2):287-9. PubMed ID: 6978327
    [No Abstract] [Full Text] [Related]

  • 18. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC, Irvin WS, May CM, Holman HR, McDuffie FC, Hess EV, Schmid FR.
    N Engl J Med; 1976 Nov 18; 295(21):1149-54. PubMed ID: 1086429
    [Abstract] [Full Text] [Related]

  • 19. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O, Haïm T.
    Nouv Presse Med; 1982 Oct 09; 11(39):2891-4. PubMed ID: 6755388
    [Abstract] [Full Text] [Related]

  • 20. [Diagnosis and clinical symptoms of systemic lupus erythematosus and overlap syndrome].
    Ichikawa Y.
    Nihon Naika Gakkai Zasshi; 1990 Oct 10; 79(10):1360-5. PubMed ID: 2269809
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.